Testing the iTremor device for measuring tiny eye movements in US adults
Checks how reliably the iTremor device measures ocular microtremor in adults.
Key facts
- Who runs it
- Head Diagnostics
- Where
- Atlanta and Cambridge, United StatesSee the 2 sites
- Trial code
- Registry title
- Measurement of Ocular Microtremor With the iTremor Device in a Diverse US Cohort
- Status
- Enrolling by invitation
- People taking part
- 120 people, planned
- Started
- 28 Sept 2026
- Expected to end
- 31 Mar 2027
- Type of study
- Observational
- Record updated
- 5 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with normal or corrected vision who can sit still and look forward for a few seconds. It tests a device that measures tiny eye movements.
- Age
- 18 years or older
- Sex
- All sexes can join.
Main reasons for not taking part
- Visible or known injury to the eye or eye socket
- Damaged skin around the eye
- Oculomotor palsy, or strabismus (cross-eyedness) or impaired eye movement
- Cannot avoid alcohol, cannabis or other recreational drugs for 24 hours before the visit
- Cannot or will not remove scleral contact lenses or glasses during the visit
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Adults 18 years of age or older
- Normal or corrected to normal bilateral vision
- Ability to sit and look forward for periods of at least 5 seconds
- Communicate in English with the study team
Who cannot take part
- Inability to refrain from alcohol, cannabis or other recreational drugs for 24 hours prior to study visit
- Conditions, not explicitly described, identified by clinical exam, which would make achieving a measurement impractical or uncomfortable for the participant
- Visible or known injuries to eye or eye socket
- Non-intact periorbital skin
- Oculomotor palsy
- Strabismus (cross-eyedness) / impaired ocular mobility
- Inability or unwillingness to remove scleral contact lenses or glasses for the length of the study visit
Where in United States
- Emory UniversityAtlanta, United StatesEnrolling by invitation
- Massachusetts Institute of TechnologyCambridge, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
To evaluate the reliability of using the iTremor device to accurately measure Ocular Microtremor (OMT) across a diverse cohort, representative of the US population, with a view to establishing this as a standard measurement tool for OMT.
The group in the trial
- 'All comers'
Participants aged 18 and over representing the gender, age and racial diversity of the US population and of varied health status.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Measurement of Ocular Microtremor With the iTremor Device in a Diverse US Cohort
- Plain-language title
- Testing the iTremor device for measuring tiny eye movements in US adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 5 October 2026